<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Change in bowel habit — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Change in bowel habit</h1>
        <div class="sub">Adults with unexplained new/persistent change in bowel habit: triage red flags, do DRE + baseline tests, use FIT to guide suspected colorectal cancer referral, and safety‑net negative/non‑returned FIT.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑11</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
<h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points (primary care)</strong>
                <ul>
                  <li><strong>NICE NG12 / NICE HTG690:</strong> offer quantitative <strong>FIT</strong> (HM‑JACKarc or OC‑Sensor) to guide suspected colorectal cancer referral in adults with <strong>change in bowel habit</strong> (and several other lower‑GI presentations).</li>
                  <li><strong>Referral threshold:</strong> refer on the suspected colorectal cancer pathway if <strong>FIT ≥10 µg Hb/g faeces</strong> (NG12; HTG690).</li>
                  <li><strong>Don’t delay</strong> referral when there is <strong>strong clinical concern</strong> (e.g. abdominal mass, ongoing unexplained symptoms) even if FIT is negative / not returned; ensure <strong>safety‑netting</strong> is in place for FIT &lt;10 or non‑return (NG12; HTG690).</li>
                  <li><strong>Rectal mass</strong> (and unexplained anal mass/ulceration) does <strong>not</strong> need FIT before referral is considered; NG12 advises considering suspected cancer pathway referral for <strong>rectal mass</strong>.</li>
                  <li>ACPGBI/BSG guidance supports FIT use in symptomatic patients, and emphasises that <strong>negative FIT does not equal “no cancer”</strong>; safety‑netting and reassessment is required for persistent symptoms and for high‑risk clinical features.</li>
                </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;&lt;li&gt;(Add 1–3 background bullets if desired.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Suspected bowel obstruction&lt;/strong&gt;: severe colicky abdominal pain, vomiting, absolute constipation, distension, peritonism.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Severe lower GI bleeding&lt;/strong&gt; with haemodynamic compromise, syncope, or ongoing large-volume bleeding.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Sepsis / acute abdomen&lt;/strong&gt;.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Abdominal exam&lt;/strong&gt;: masses, focal tenderness, distension.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Digital rectal examination (DRE)&lt;/strong&gt;: rectal mass; stool/bleeding; fissure/haemorrhoids (document clearly).&lt;/li&gt;
                &lt;li&gt;If symptoms include PR bleeding: also use the separate &lt;a href="./pr-bleeding.html"&gt;PR bleeding&lt;/a&gt; page for triage and baseline tests.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Offer quantitative FIT&lt;/strong&gt; (HM‑JACKarc or OC‑Sensor) in adults with &lt;strong&gt;unexplained change in bowel habit&lt;/strong&gt; (plus other NG12/HTG690 indications).&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;FIT ≥10 µg Hb/g faeces&lt;/strong&gt; → &lt;strong&gt;refer using suspected colorectal cancer pathway&lt;/strong&gt; (2WW equivalent) (NICE NG12 / HTG690).&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;FIT &amp;lt;10 µg Hb/g&lt;/strong&gt; OR &lt;strong&gt;sample not returned&lt;/strong&gt;:
                  &lt;ul&gt;
                    &lt;li&gt;Ensure &lt;strong&gt;safety‑netting&lt;/strong&gt; (planned review, clear return precautions, and a pathway for escalation).&lt;/li&gt;
                    &lt;li&gt;&lt;strong&gt;Do not delay referral&lt;/strong&gt; if strong clinical concern persists (e.g. mass, ongoing unexplained symptoms, significant weight loss) (NICE NG12 / HTG690).&lt;/li&gt;
                  &lt;/ul&gt;
                &lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;&lt;li&gt;(If no explicit ‘who not to refer’ applies, omit or keep minimal.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;&lt;li&gt;(Add references here.)&lt;/li&gt;&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
<h3>Change in bowel habit — adults (suspected colorectal cancer framing)</h3>

              <h4>Immediate red flags (999 / ED now)</h4>
              <ul>
                <li><strong>Suspected bowel obstruction</strong>: severe colicky abdominal pain, vomiting, absolute constipation, distension, peritonism.</li>
                <li><strong>Severe lower GI bleeding</strong> with haemodynamic compromise, syncope, or ongoing large-volume bleeding.</li>
                <li><strong>Sepsis / acute abdomen</strong>.</li>
              </ul>

              <h4>Urgent suspected cancer pathway (do not wait for FIT)</h4>
              <ul>
                <li><strong>Rectal mass</strong> on DRE (NICE NG12: consider suspected cancer pathway referral).</li>
                <li><strong>Unexplained abdominal mass</strong> (NICE NG12 / HTG690: FIT can be offered, but referral should not be delayed if clinical concern is high).</li>
              </ul>

              <h4>Step 1 — define the problem (is it truly “unexplained” and persistent?)</h4>
              <ul>
                <li><strong>Clarify change</strong>: new change from baseline (stool frequency/form, urgency/tenesmus, diarrhoea vs constipation, alternating pattern, nocturnal symptoms).</li>
                <li><strong>Duration</strong>: persistent / recurrent; document start date.</li>
                <li><strong>Associated symptoms</strong>: PR bleeding, weight loss, abdominal pain, mucus, fevers, anaemia symptoms, family history of colorectal cancer/polyposis.</li>
                <li><strong>Medication and reversible causes</strong>: antibiotics (C. diff risk), metformin, PPIs, opioids, iron, laxatives, dietary change, new alcohol excess; recent travel/infective contacts.</li>
              </ul>

              <h4>Step 2 — examination (don’t skip)</h4>
              <ul>
                <li><strong>Abdominal exam</strong>: masses, focal tenderness, distension.</li>
                <li><strong>Digital rectal examination (DRE)</strong>: rectal mass; stool/bleeding; fissure/haemorrhoids (document clearly).</li>
                <li>If symptoms include PR bleeding: also use the separate <a href="./pr-bleeding.html">PR bleeding</a> page for triage and baseline tests.</li>
              </ul>

              <h4>Step 3 — baseline investigations (typical primary care set)</h4>
              <ul>
                <li><strong>FBC</strong> (anaemia) and <strong>ferritin/iron studies</strong> if anaemia suspected.</li>
                <li>Consider: U&amp;Es/eGFR, LFTs, CRP (if inflammatory features), coeliac serology where appropriate, and stool tests if infective diarrhoea suspected.</li>
              </ul>

              <h4>Step 4 — use FIT to guide suspected colorectal cancer referral (NICE NG12 / HTG690)</h4>
              <ul>
                <li><strong>Offer quantitative FIT</strong> (HM‑JACKarc or OC‑Sensor) in adults with <strong>unexplained change in bowel habit</strong> (plus other NG12/HTG690 indications).</li>
                <li><strong>FIT ≥10 µg Hb/g faeces</strong> → <strong>refer using suspected colorectal cancer pathway</strong> (2WW equivalent) (NICE NG12 / HTG690).</li>
                <li><strong>FIT &lt;10 µg Hb/g</strong> OR <strong>sample not returned</strong>:
                  <ul>
                    <li>Ensure <strong>safety‑netting</strong> (planned review, clear return precautions, and a pathway for escalation).</li>
                    <li><strong>Do not delay referral</strong> if strong clinical concern persists (e.g. mass, ongoing unexplained symptoms, significant weight loss) (NICE NG12 / HTG690).</li>
                  </ul>
                </li>
              </ul>

              <h4>Pragmatic safety-net triggers (examples)</h4>
              <ul>
                <li><strong>Reassess promptly</strong> if symptoms persist/worsen despite negative FIT, especially if:
                  <ul>
                    <li>new/persistent <strong>iron‑deficiency anaemia</strong></li>
                    <li><strong>weight loss</strong></li>
                    <li>progressive pain, or any palpable mass</li>
                    <li>recurrent PR bleeding</li>
                    <li>strong family history / high clinical concern</li>
                  </ul>
                </li>
                <li>Consider (local policy): <strong>repeat FIT</strong> after an interval in persistent symptoms, and/or referral via an <strong>alternative pathway</strong> (e.g. non‑specific symptoms, direct access imaging) when cancer remains plausible.</li>
              </ul>

              <h4>Who to refer / where to send (D&amp;G placeholders)</h4>
              <ul>
                <li><strong>999 / ED</strong>: obstruction, severe bleeding, acute abdomen, sepsis.</li>
                <li><strong>Suspected colorectal cancer pathway</strong>: FIT ≥10 µg Hb/g; rectal mass; or strong clinical concern (don’t delay for FIT).</li>
                <li><strong>Routine gastro/colorectal / alternative pathway</strong>: persistent symptoms with repeatedly negative FIT where non-malignant causes are more likely, but symptoms still need secondary-care assessment (local route).</li>
                <li><strong>Advice &amp; guidance</strong>: uncertainty about FIT use, thresholds, repeat testing, or best next investigation (colonoscopy vs CT colonography) when FIT is negative but concern remains.</li>
              </ul>

              <h4>Referral-letter minimum (suggested)</h4>
              <ul>
                <li>Exact symptom description (what changed), onset date, persistence, associated PR bleeding/weight loss/pain.</li>
                <li>Exam findings: abdomen + <strong>DRE</strong> (and whether rectal mass present).</li>
                <li>Results: <strong>FIT value</strong> (with date) and baseline bloods (FBC ± ferritin/iron studies ± CRP).</li>
                <li>PMH and meds relevant to bleeding risk (anticoagulants/antiplatelets) and GI symptoms.</li>
              </ul>

              <h4>Local agreement needed (add D&amp;G specifics)</h4>
              <ul>
                <li class="check">What is the local <strong>default pathway</strong> for FIT ≥10: colorectal 2WW clinic vs direct-access colonoscopy vs CT colonography triage?</li>
                <li class="check">Local position on <strong>repeat FIT</strong> (when and for whom) if FIT &lt;10 but symptoms persist.</li>
                <li class="check">What pathway is used for <strong>negative FIT but ongoing high clinical concern</strong> (non‑specific symptoms route? direct access imaging? A&amp;G with colorectal?)</li>
                <li class="check">Expected baseline tests before referral (FBC + ferritin? CRP? coeliac serology?) and any local proformas.</li>
                <li class="check">Handling of patients on <strong>anticoagulants/antiplatelets</strong>: any local advice for FIT interpretation or referral thresholds?</li>
              </ul>

              <div class="callout warn">
                <strong>Safety net</strong>
                <div class="small">A negative FIT reduces colorectal cancer probability but does not eliminate it. If symptoms persist or clinical concern remains high, reassess and escalate via the appropriate pathway.
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑06)</h3>
              <ol>
                <li>RCOG Green‑top Guideline No. 34: Ovarian Cysts in Postmenopausal Women (consensus update Dec 2025; web page last reviewed 05 Dec 2025). <a href="https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/ovarian-cysts-in-postmenopausal-women-green-top-guideline-no-34/">rcog.org.uk</a></li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (ovarian cancer section; CA‑125 ≥35 → USS). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Right Decisions (GGC primary care): Ovarian cysts in post-menopausal women (example of local thresholds/RMI approach; not D&amp;G). <a href="https://www.rightdecisions.scot.nhs.uk/ggc-primary-care/womens-health/gynaecology-clinical-guidelines/ovarian-cysts-in-post-menopausal-women-549/">rightdecisions.scot.nhs.uk</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
